Author : Acumen Research and Consulting

The global hematology diagnostics market can be segmented on the basis of product and geography. While talking about the product basis, it can be divided further into instruments and consumables. Additionally the instruments segment can be bifurcated into reagents, stains, and others. The primary factors which have pushed the global hematology diagnostics market to grow include technological advancements and introduction of new product varieties in the recent years. There has been a growing focus on the effective diagnosis of the rising cases of blood disorders in both developing and developed economies; this is consequently boosting the growth of the hematology diagnostics market on a global front.

In other words, growing concerns related to health, ever increasing diseases and continuous innovations and the numerous benefits offered by the Hematology diagnostics such as less pain, optimal moisture level maintenance and quicker wound closure have boosted the growth of the global Hematology diagnostics market. According to estimates, the global Hematology diagnostics market is expected to reach a value of USD 9.54 Bn by 2026 growing at a CAGR of around 5.8%.

Here are some more points to help explain about the global Hematology diagnostics market:

• Consumables segment are foreseen continue its dominance over the forecast time frame pertaining to the growing demand for consumables due to rise in blood disorders and other infectious diseases.
• The growth of the instruments segment is being propelled by the increasing automation and technological advancements.
• In 2017, the highest share in terms of income contribution is concerned; was secured by Blood Count. It is expected that it will keep growing at a significant CAGR level in the forecast period. Complete Blood Count (CBC) tests are valuable for general assessment of wellbeing amid routine check-ups. Conditions, such as, allergy, anemia, iron and vitamin deficiencies, and infections, are easily diagnosed through these tests.
• According to geographical segmentation, the North American region held the largest share of the global Hematology diagnostics market in 2017. There were several causes including expanding geriatric populace, ideal repayment situation, innovative technological facilities, and presentation of cutting edge innovations for the POC test; which can be ascribed to the development in the region.
• The highest growth is expected in the Asia- Pacific regional market.
• The major players operating in this market are Abbott Laboratories, Ortho Clinical Diagnostics, Sysmex Corporation, Boule Diagnostics, F. Hoffmann-La Roche Ltd., Drew Scientific, Bio-Rad Laboratories, EKF Diagnostics, and Beckman Coulter, Inc.

Download Report Sample Pages For Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/935

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157